VR Logo

Science 37 Holdings Inc. (SNCE) download report


Healthcare | Health Services

Science 37 Holdings Inc. (SNCE) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Science 37 Holdings, Inc. engages in the development of a technology platform to enable agile clinical trials and specialized networks to orchestrate trial execution.

IPO Date: 20-Nov-2020

CEO & Director: Mr. David Coman

Chief Legal Officer & Sec.: Ms. Christine A. Pellizzari J.D.

Listing: NASDAQ: SNCE

Country: United States

Headquarters: Research Triangle Park, NC

Website: https://www.science37.com

Key Facts

Market cap: $330.26 Mln

Revenue (TTM): $39.06 Mln

Earnings (TTM): $-42.61 Mln

Cash: $179.55 Mln

Total Debt: $2.16 Mln

Insider's Holding: 22.18%

Liquidity: Low

52 Week range: $2.34 - 15.10

Shares outstanding: 115,881,000

Stock Performance

Time Period Science 37 Holdings (SNCE) S&P BSE Healthcare* S&P Small-Cap 600*
YTD-80.99-17.06-17.14
1 month-33.24-3.28-4.85
3 months-54.77-10.69-12.74
1 Year-76.65-13.41-16.37
3 Years--19.057.97
5 Years--9.236.33
10 Years--12.3910.54
As on 27-Jun-2022 *As on 28-Jun-2022
Year Science 37 Holdings (SNCE) S&P Small-Cap 600 S&P BSE Healthcare
202116.8725.2720.87